/Investor DB

F-Prime Capital — 2023 Investments

29 investments dated 2023 · listed companies and verified rows first · show all

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRASeries A · Jan 2023 · $400M

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Board seatStacie Weninger· per SEC Form D

Co-investorsARCH Venture PartnersCatalio Capital Management, LPK2 HealthVenturesMercury FundPremier PartnersSoftBank Vision Fund+12 more

Avalyn Pharma Incavalynpharma.cominNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera PartnersCatalio Capital Management, LPInVivium CapitalNorwest Venture PartnersPivotal Life SciencesRiverVest Venture Partners+9 more

Bicara Therapeuticsbicara.comin𝕏NASDAQ: BCAXSeries B · Mar 2023 · $110M

Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.

Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)inDavid Raben(Chief Medical Officer)in

Co-investorsAisling CapitalEight Roads VenturesForesite CapitalPremji InvestRA CapitalRed Tree Venture+6 more

Nflection Therapeuticsnflection.cominJul 2023✓ verified

NFlection is a biopharmaceutical company developing novel therapeutics.

BiotechMedical DevicesBoston, US

Christopher Powala(Chief Development Officer, Former President & CEO)Mark de Souza(Executive Officer, Director)in

BoardCorey Goodman(Director)Ketan Patel(Director)in

Co-investorsvenBio PartnersvenBio Global Strategic

1Uphealth1up.healthin𝕏Series B · Apr 2023 · $25M

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories.

Data & InfrastructureDigital HealthHealthtechBoston, US

Ritwik Sahu(Executive Officer, Director)Ricky Sahu(Founder)inJoseph Gagnon(Director)Andrew Boyd(Chief Executive Officer)in

BoardVictor Echevarria(Director)inDavid Jegan(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsEniac VenturesJackson Square VenturesMeridian Street CapitalSixth StreetSocial Leverage

CHARM Therapeuticscharmtx.cominSeries A · Apr 2023 · $50M

CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.

AI & Machine LearningBiotechHealthtechLondon

Lakshyaditya Singh Aithani(Executive Officer, Director)David Baker(Founder)Laksh Aithani(Founder)

BoardRishi Gupta(Director)inMuzammil Mansuri(Director)in

Board seatMuz MansuriNihal Sinha· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)NVIDIAOrbiMedSR One Capital ManagementAxial VCKhosla Ventures+1 more

Ensomaensoma.comSeries A · Jan 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)

Board seatStephen Knight· per SEC Form D

Co-investors5AM VenturesAju IB InvestmentCatalio Capital Management, LPDelos CapitalSolasta VenturesViking Global+10 more

Rarecyterarecyte.comJul 2023 · $24M

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

BoardRobert Shepler(Director)in

Board seatRobert Weisskoff· per SEC Form D

Co-investors5AM VenturesArboretum VenturesTelegraph Hill PartnersHealthQuest CapitalSofinnova Ventures

Tradiertradier.cominSeries A · Apr 2023 · $24.6M

Tradier offers REST-based APIs and trading platforms providing equity, options, and futures trading, account management, market data, and brokerage services for individual developers and businesses.

FintechSaaSCharlotte, US

Dan Raju(Executive Officer, Director)inPeter Laptewicz(Executive Officer, Director)inRobert Kopple(Director)

BoardAlec Petro(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsDevonshire Investors

Zus Healthzushealth.comin𝕏Mar 2023

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

Cloud ComputingData & InfrastructureDigital HealthHealthtechWatertown, US

Jonathan Bush(CEO)inTravis Smith(Executive Officer)inJonathan S. Bush(Founder)

BoardSteven Fisher(Director)Fay Rotenberg(Director)Julie Yoo(Director)in

Board seatCarl Byers· per SEC Form D

Co-investorsAdvection Growth CapitalAlumni VenturesAndreessen HorowitzJAZZ Venture PartnersMartin VenturesMaverick Ventures+1 more

Adcentrx Therapeuticsadcentrx.cominApr 2023

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.

BiotechHealthtech

Hui Li(Founder, President & CEO)in

Co-investorsEight Roads VenturesQuan CapitalDelta Capital

Albert Inventalbertinvent.cominJun 2023

Albert provides an operating system for chemists that combines structured data management with AI trained on molecular structures and individual company chemistry datasets.

AI & Machine LearningDeep TechEnterprise Software

Zach Kisner(Co-founder)inKen Kisner(Founder)inNick Talken(Founder)inNeelesh Vaikhary(Co-founder)inZack Kisner(Founder)in

Co-investorsBlue Trail PartnersCapitalGCoatue ManagementCoral CapitalHomebrewIndex Ventures+2 more

ARTBIOartbio.comin𝕏Seed · Dec 2023 · $23M

ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue.

BiotechHealthtechMedical DevicesOslo, NO

Roy Larsen(Scientific Co-Founder)Øyvind Bruland(Scientific Co-Founder; SAB Chairman)Margaret Yu(Chief Medical Officer)inPhilippe Dasse(Chief Technical Officer)inAmra Demirovic(Chief Human Resources Officer)inNicole Hadas(Chief Legal Officer)

Co-investorsB Capital GroupB4 CapitalSofinnova VenturesAlexandriaB CapitalOmega Funds+2 more

Better Life Partnersbetterlifepartners.comin𝕏Series B · Aug 2023 · $27M

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.

Digital HealthHealthtechMental HealthHanover, US

Adam Groff(Executive Officer, Director)inJuliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)

BoardYair Schindel(Director)inJon Lim(Director)in

Co-investorsAlumni VenturesaMoon.406 VenturesMaverick Ventures

Cadence Neurosciencecadenceneuro.cominMay 2023 · $26M

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture PartnersLumira VenturesAngelini VenturesIaso VenturesMayo Clinic Ventures

Carrot Fertilityget-carrot.comin𝕏Series C · Jun 2023

Carrot is a global fertility and family-building platform that provides access to fertility care, maternity support, and family-building guidance for individuals and families.

FemTechHealthtechHR TechSan Francisco, US

Asima Ahmad(CMO)inTammy Sun(CEO, co-founder)inDavid Utley(Executive Officer, Director)Dr. Asima Ahmad(Founder)Arun VenkatesanMaxwell Radomsky

Co-investors515 VenturesAll TurtlesAurumBackstage CapitalCore Venture CapitalCRV (Charles River Ventures)+18 more

Docereedoceree.comin𝕏Series A · Sep 2023 · $35M

Doceree offers a software platform for pharmaceutical brand teams, positioned as a single "system of work" that unifies market research, HCP targeting, media planning, measurement, CRM, and MLR workflows in place of fragmented tools.

AdTechDigital HealthMarketing TechSaaSShort Hills, US

Harshit Jain(Founder & Global CEO)inKamya Elawadhi(Co-Founder & President)inPulkit Jain(VP - Finance & Investments)inVijay Adapala(Chief Business Development Officer)inThomas Shea(Chief Revenue Officer, AI and Patient Affordability Solutions)inYesh Srinivasan(Chief AI Officer)

Co-investorsAlkemi Growth CapitalEight Roads Ventures

Eleoseleos.co.ukin𝕏Nov 2023 · $40M

Eleos offers life insurance and income protection to consumers in the UK, with an app-based process that explains cover in plain English, provides instant answers, and connects users to licensed experts by WhatsApp, email, or phone.

FintechInsurTech

Co-investorsaMoonArkin CapitalFuel VenturesHeartfelt CapitalInsurTechEight Roads Ventures+4 more

Eleos Healtheleos.healthinSeries A · Nov 2023 · $40M

Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.

AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US

Alon Joffe(Founder)inDror Zaide(Founder)inAlon Rabinovich(Founder)inDenny Morrison(Chief Clinical Officer)inRaz Karmi(Chief Information Security Officer)inNoam Cohen(VP of R&D)in

Co-investorsaMoonArkin CapitalArkin Digital HealthGaingelsGreenfield PartnersLool Ventures+5 more

Enzene Biosciences Ltdenzene.comin𝕏Jan 2023 · $50M

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals.

Advanced ManufacturingBiotechHealthtechMedical Devices

Co-investorsEight Roads Ventures

K36 Therapeuticsk36tx.comin𝕏Series A · Jun 2023 · $70M

A biotechnology company developing cancer therapies for patients with unmet medical needs.

BiotechHealthtech

Co-investorsAtlas VentureNextech InvestEight Roads Ventures

Notablenotablehealth.comin𝕏Apr 2023

Notable is an AI platform for healthcare organizations that uses AI agents to automate administrative and operational work across patient access, revenue cycle management, and care operations.

AI & Machine LearningDigital HealthHealthtechSan Mateo, US

Justin White(Founder)inPranay Kapadia(Founder)inAdam Ting(Founder)inJustin White, PhD(Co-Founder & CTO)Aaron Neinstein, MD(Chief Medical Officer)inRyan Pfeffer(Head of Engineering)in

Co-investors8VCEnsemble LabsFelicis VenturesGreylock PartnersICONIQICONIQ Growth+4 more

Shinobi Therapeutics Inc.shinobitx.cominSeries A · Dec 2023 · $51M

Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsAstellas Venture Management LLCFast Track InitiativeJIC Venture Growth InvestmentsKyoto University Innovation CapitalEQT Life Sciences

T Therapeuticst-therapeutics.cominSeries A · Nov 2023 · $60M

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsCambridge Innovation CapitalSanofi VenturesSofinnova PartnersBusiness Growth FundDigitalis VenturesUniversity of Cambridge Enterprise

Tandemaitandemai.comin𝕏Series A · Mar 2023 · $35M

TandemAI combines AI-driven techniques with physics-based computational methods, backed by in-house high-performance computing and wet lab operations, to support drug discovery.

AI & Machine LearningBiotechDeep TechHealthtechSaaS

Co-investorsOrbiMedQiming Venture Partners

Tenpoint Therapeuticstenpointtherapeutics.comin𝕏Series A · Jul 2023 · $70M

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye.

BiotechDigital HealthHealthtechLongevityMedical DevicesWarren, US

HENRIC BJARKE(Chief Executive Officer)in

Co-investorsAdBio partnersQiming Venture Partners USASofinnova PartnersQiming Venture Partners

Warmlywarmly.aiin𝕏Seed · Oct 2023 · $11Macquired by HubSpot, Inc. · Jun 2026

Warmly is an AI-powered sales prospecting and outreach platform that helps companies identify and engage with qualified leads, reducing the need for traditional Sales Development Representative services.

AI & Machine LearningEnterprise SoftwareSales TechSan Francisco, US

Max Greenwald(Founder)inCarina Boo(Founder)inAlan Zhao(Founder)inmaximus greenwald(Founder)inMaximus Greenwald(Founder)Val Yermakova(Founder)

Co-investorsFelicis VenturesGaingelsMatchstick VenturesMaven VenturesNFXRTP Global+10 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BTP AutomationCanoe

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.